Blogs

Eight out of 10 American seniors take at least two prescription drugs daily, a fate I’ve been determined to avoid. But a stubborn illness helps me understand why it’s so tempting to reach for pharmaceutical solutions.

Wisdom from a palliative-care doctor helps me absorb both the enormous toll of the pandemic and the imminent demise of my brother.

Driven by the demands of a broken business model, nursing homes opened their doors to coronavirus patients — with predictable results.

An anxious journey to visit my dying brother offers a powerful argument against fleeing from sorrow and pain.

Recent research suggests the elderly are coping more effectively than their younger peers with the emotional challenges of the pandemic. In my case, at least, that may have more to do with conditions and coincidence than acquired wisdom.

In the pursuit of some genuine empathy in the wake of my brother’s cancer diagnosis, I find surprising wisdom in one young woman’s battle with the disease.

All indications suggest seniors may be wise to temper their expectations about a forthcoming COVID-19 vaccine.

Non-COVID hospital admissions have dropped precipitously since the pandemic struck, leading some to suggest our precautions have somehow made us healthier. I have my doubts.

As my brother tumbles into the cancer vortex, I find myself struggling to find ways to express my grief and show my support.

Many factors affect our access to healthcare, but new research suggests that where we choose to live may actually enhance — or limit — our lifespan.

Elderly Americans who volunteer for drug trials seldom make the cut. That makes it more difficult for researchers to know just how their new product will work for folks who often need it the most.

Recent research suggests cholesterol-reducing drugs may be safer than once thought and offer cancer- and COVID-fighting benefits. So, why do I remain unconvinced?